Intratracheal administration to the lung enhances therapeutic benefit of an MBP peptide in the treatment of murine experimental autoimmune encephalomyelitis.

Source:http://linkedlifedata.com/resource/pubmed/id/10779404

Download in:

View as

General Info

PMID
10779404